Proethic Pharmaceuticals Private Limited, a active private limited company, was established on 12 October 2009 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL2009PTC195127. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Kamlesh (Director), Vikas Malik (Director). Past directors included Mohammad Naushad Alam, Avinash Nagabhushanam Polepalli, Manoj Kumar Mutha. It holds ₹0.77 M open charges and ₹1.97 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D-80 New Multan Nagar, Delhi, Delhi, 110056.
U24232DL2009PTC195127
195127
12 October 2009
₹1.00 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Proethic Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamlesh | Director | 09 Mar 2018 | Current |
| Vikas Malik | Director | 12 Oct 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 03 Feb 2018 | Past |
| Pramod Abcsdd | Director | 24 May 2011 | Past |
| Pramod Abcsdd | Director | 16 Sep 2017 | Past |
| Pramod Abcsdd | Director | 01 Oct 2010 | Past |
| Pramod Abcsdd | Director | 01 Dec 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Proethic Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 54.1% decrease. The company also saw a substantial fall in profitability, with a 241.83% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Proethic Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹766,000.00
₹1,966,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2018 | Others | ₹0.77 M | Satisfied |
| 18 Dec 2010 | Canara Bank | ₹1.20 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Proethic Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Proethic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proethic Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Proethic Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity A charge registered on 30 Jul 2018 via Charge ID 100244100 with Others was fully satisfied on 11 Jun 2025. was completed.
Proethic Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
A charge with Others amounted to Rs. 0.77 M with Charge ID 100244100 was registered on 30 Jul 2018. was recorded as a recent event.
A charge registered on 18 Dec 2010 via Charge ID 10259981 with Canara Bank was fully satisfied on 20 Jun 2018. was recorded as a recent event.
The activity Kamlesh was appointed as a Director was appointed as a Director on 09 Mar 2018 & has been associated with this company since 7 years 8 months . was completed.
The CIN of Proethic Pharmaceuticals Private Limited is U24232DL2009PTC195127.
Proethic Pharmaceuticals Private Limited is headquartered at D-80 New Multan Nagar, Delhi, Delhi, 110056.
Proethic Pharmaceuticals Private Limited was incorporated on 12 October 2009.
The current directors of Proethic Pharmaceuticals Private Limited are
The primary industry of Proethic Pharmaceuticals Private Limited is Manufacturing.
Proethic Pharmaceuticals Private Limited is unlisted.
The authorized capital of Proethic Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Proethic Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX